Category: Markets and Macro

Canada’s economy is being squeezed from several directions at once, and the most immediate pressure point is the tariff agenda coming out of Washington. President Donald Trump’s escalating duties and threats of even higher levies are colliding with a fragile domestic backdrop, turning a policy fight into a real risk of recession north of the…

When markets plunge and headlines scream crisis, Peter Lynch’s message is blunt: if you cannot stomach deep drawdowns, you probably should not own stocks. His warning is not meant to scare people out of investing, but to force them to confront what real risk looks like before the next selloff hits. I see his approach…

Scientists, risk analysts and farm leaders are converging on a stark message: the climate crisis is no longer a distant environmental issue but a direct threat to the global economy. From food systems to finance, they warn that current policies and models are steering governments toward a slow-motion crash. If we want to avoid a…

Drivers in parts of the country are suddenly seeing something they have not glimpsed in years: regular gas starting with a “1” on the station marquee. Prices have slipped below $2 a gallon in nine states, giving households a rare bit of breathing room at a time when other costs remain stubbornly high. President Donald…

The United States just crossed a psychological line on Wall Street, and the political establishment is racing to claim credit. As The Dow vaults to a historic peak, Treasury Secretary Scott Bessent is doubling down on his promise of a “blockbuster” 2026, arguing that the rally reflects deeper strength in growth, trade and manufacturing rather…

The crypto industry is hurtling toward a breaking point, with Bullish CEO Tom Farley warning that a wave of failures and forced tie-ups is no longer a distant risk but an immediate reality. After years of easy funding and lofty token prices, he argues that many digital asset businesses now sit on a “merge or…

Wall Street is betting that Eli Lilly can turn its obesity and diabetes franchise into one of the most powerful growth engines in global pharmaceuticals, with analysts projecting revenue to climb more than 21% and adjusted earnings to rise more than 40% by 2026. Those expectations rest on a mix of surging demand for GLP-1…

President Donald Trump’s signature education package, the One Big Beautiful Bill Act, is about to collide with the traditional college business model. By capping how much families can borrow, shrinking repayment safety nets and taxing wealthy campuses more heavily, the law could simultaneously squeeze enrollment and push institutions to rethink who they serve and how….

The United States has crossed a line that once seemed unthinkable: paying more than $1 trillion a year just to service its national debt. With total obligations now approaching $40 trillion and interest costs rising faster than tax revenues, the federal balance sheet is tilting toward a structural crisis rather than a passing rough patch….

The Dow Jones Industrial Average has finally vaulted over the 50,000 mark, a psychological barrier that once sounded like science fiction on Wall Street trading floors. The move caps a blistering run powered by artificial intelligence enthusiasm, resilient corporate profits and a U.S. economy that, while slowing at the edges, is still expanding. The question…